
Hybrid drug combination: Anti-diabetic treatment of type 2 diabetic Wistar rats with combination of ellagic acid and pioglitazone
Keywords: گاما گیرنده گیرنده فعال پرولیفیزوم فعال; Type 2 diabetes; Ellagic acid; Synergy; Pioglitazone; Adiponectin; BW; body weight; cDNA; complementary deoxyribonucleic acid; CT; threshold cycle; DPP-4; dipeptidyl peptidase-4; GLP-1; glucagon-like peptide-1; HDL; high density lipoprotein; H&E; hematoxy